C12N 2770/28143
Viral genome or elements thereof as genetic vector
Official title: viral genome or elements thereof as genetic vector
C12N2770/28143 (Viral genome or elements thereof as genetic vector) appears on 2 US grants and 4 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 4
- Assignees
- 5
- Inventors
- 9
- Latest grant
- 26 Dec 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Virus-like nanocapsid for oral delivery of insulin11 Jun 2026US 2026/0159817 A1The Regents of the University of California
- Virus-like nanocapsid for oral delivery of insulin11 Feb 2021US 2021/0038697 A1The Regents of the University of California
- Infectious hepatitis e virus genotype 3 recombinants14 Apr 2016US 2016/0102296 A1Royal Cornwall Hospital Trust
- Infectious hepatitis e virus genotype 3 recombinants14 Nov 2013US 2013/0302790 A1Royal Cornwall Hospital Trust
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.